PGI Lecture Reveals Alarming Rise of NCDs in India
A PGI lecture revealed an epidemic of undiagnosed lifestyle diseases in Chandigarh. Over 100 attendees learned how obesity and diabetes are driving heart disease. Act now to protect your health.
Category : Search result: obesity reduction drugs
Soybean Oil Linked to Obesity in New Study
Groundbreaking UC Riverside research reveals how America's favorite cooking oil contributes to weight gain and metabolic disorders. Learn the science behind soybean oil's impact on your health.
7 Signs Your Child's Weight Needs Attention
A bariatric surgeon reveals 7 crucial signs that childhood weight issues may indicate serious health problems. Learn to spot early warnings for diabetes, heart issues, and joint problems.
Oral Weight-Loss Pill Orforglipron: Ozempic 2.0
Eli Lilly's daily pill orforglipron shows 12% weight loss in trials, potentially revolutionizing obesity treatment. Could this be the end of injections?
Bariatric Experts Tackle India's Obesity & Diabetes Crisis
Leading bariatric specialists Dr. Todkar, Dr. Dukkipati & Dr. Garg share crucial insights on managing India's dual health crisis through early intervention & lifestyle changes. Act now for better health!
India's Childhood Obesity Crisis: Rates Hit 9%
Childhood obesity in India surges from 3-4% to 8-9%, driven by lifestyle changes and mental health factors. Dr. Atul Peters reveals how families can reverse this alarming trend through simple changes.
Indian Companies Set for Semaglutide Device Windfall
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
Indian Pharma Pivots to Innovative Products: PHARMEXCIL
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
1 in 4 Indian Adults Obese, Rates Soar 5-Fold
A new report reveals a sharp 5-fold increase in obesity in India over 30 years, affecting 1 in 4 adults. Learn about the health risks and what it means for the nation.
1 in 4 Indians Obese: ₹29 Billion Economic Impact
New Lancet study reveals 25% of Indians face obesity, costing economy ₹29,000 crore annually. Urgent public health action needed to address this growing crisis.
Insurance Hurdles Deny Obesity Care: OSSI Study
New OSSI survey reveals insurance barriers prevent timely obesity treatment in India. Learn how policy gaps affect patient care and what needs to change.
PGI: Type 2 Diabetes Surging in Children as Young as 10
PGI Chandigarh warns of a sharp increase in Type 2 diabetes among children and young adults, driven by junk food and sedentary lifestyles. Learn how to prevent it.
India's UPF Crisis: 40-Fold Surge Fuels Health Risks
Lancet study reveals India's ultra-processed food epidemic with retail sales skyrocketing 40-fold since 2006, driving obesity and diabetes crisis among youth. Experts demand urgent policy reforms.
6 Lifestyle Diseases Plaguing Modern India
Discover the top 6 lifestyle diseases affecting Indians, their causes, symptoms, and preventive measures. Learn how to protect your health today!
Novo Nordisk Cuts Wegovy Price, Eyes Oral Pill Launch
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Novo Nordisk brings back former CEO as chairman
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Bittu Urges Support for Chitta-Free Himachal Campaign
Union Minister Bittu appeals to Himachal residents to support anti-drug campaign. Learn how communities can fight drug menace together for a safer state.
Assam Police Fitness: 2.06% Obese in BMI Drive
Assam Police reports significant fitness improvement with only 2.06% of 73,317 personnel classified as obese in annual BMI tests. Discover how the force is getting leaner and mission-ready.
Mumbai teen beats Type 2 diabetes with lifestyle overhaul
A 16-year-old Mumbai student reversed his Type 2 diabetes risk factors. Discover how an endocrinologist's plan involving diet, exercise, and family support led to a 7 kg weight loss and improved HbA1c levels in six months.
Arjun Kapoor on Therapy, Mental Health & Obesity
Arjun Kapoor speaks candidly about his mental health journey, starting therapy during lockdown, and overcoming obesity. Read his powerful message on strength.
Man dies after weight-loss surgery to impress in-laws
A 36-year-old Chinese man died days after gastric bypass surgery he hoped would help him impress his girlfriend's parents. The tragedy sparks debate about weight-loss surgery risks.
Child hypertension doubled since 2000: Lancet study
Lancet study shows child hypertension doubled 2000-2020. 114 million affected globally. Obesity, poor diet, sedentary lifestyles identified as key triggers. Learn prevention strategies.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces its weight loss drug Wegovy's price by 37% in India, intensifying competition with Eli Lilly's Mounjaro. Get the latest details on the new pricing and market dynamics.
Medicare Deal Slashes Obesity Drug Prices for Millions
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Youth Health Crisis: Obesity & Heart Attacks Rising in India
Medical experts warn of alarming surge in obesity and heart attacks among young Indians. Discover how adopting Blue Zone lifestyle principles could reverse this dangerous trend.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Obesity Drugs: Not Miracle Cures
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
Page 3 of 4